Ya-Bing Zheng

Most-cited papers

1. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion

   Ying-ying Cui, Li Yan, Jing Zhou, Shan Zhao +5 more

   2016Tumor Biology27 citations

   Semantic Scholar

   Save

2. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women

   W. Cao, Ya-Bing Zheng, Yun Gao, Xiao-Wen Ding +6 more

   2019BMC Cancer21 citations Open access

   Semantic Scholar

   Save

3. Overexpression of ILK1 in breast cancer associates with poor prognosis

   Hong-Jian Yang, Ya-Bing Zheng, Ting Ji, Xian-Feng Ding +3 more

   2013Tumor Biology15 citations

   Semantic Scholar

   Save

4. Inhibitor Response to HER2 G776YVMA In-frame Insertion in HER2-positive Breast Cancer

   Ya-Bing Zheng, Yang Yu, Bo Chen, Jin-Lin Hu +2 more

   2016Cancer Investigation7 citations

   Semantic Scholar

   Save

5. Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure

   Jian Huang, Ping Huang, X. Shao, Yan Sun +9 more

   2020Medicine2 citations Open access

   Semantic Scholar

   Save

6. The population characteristic analysis in RecurIndex for clinical decision-making on adjuvant therapy for early breast cancer: Results of a real-world study.

   Xiaojian Wang, L. Lei, P. Fu, Ou-Chen Wang +12 more

   2022Journal of Clinical Oncology0 citations

   Semantic Scholar

   Save

7. Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study.

   Xiabo Shen, Guang-Liang Li, Ya-Bing Zheng, Zhanhong Chen +3 more

   20210 citations

   Semantic Scholar

   Save

8. Ki67 and PR to predict sensitivity of palbociclib: A real-world study.

   X. Shao, Xiabo Shen, Guang-Liang Li, Ya-Bing Zheng +3 more

   20210 citations

   Semantic Scholar

   Save

9. [Clinical features and risk factors for recurrence in mucinous breast cancer].

   L. Lei, Zhanhong Chen, Ya-Bing Zheng, Bo Chen +2 more

   2017Zhonghua zhong liu za zhi [Chinese journal of oncology]0 citations

   Semantic Scholar

   Save

10. Abstract P5-09-02: The CYP19 RS4646 polymorphism is related to the prognosis of stage I–II and operable stage III breast cancers

    X. Shao, Xiao-Jia Wang, Ya-Bing Zheng, Ping Huang +1 more

    20150 citations

    Semantic Scholar

    Save